OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive Breast Cancer and Alternative Treatment Strategies
Chun‐Ming Chang, Ho Yin Pekkle Lam
Anticancer Research (2023) Vol. 43, Iss. 12, pp. 5283-5298
Open Access | Times Cited: 6
Chun‐Ming Chang, Ho Yin Pekkle Lam
Anticancer Research (2023) Vol. 43, Iss. 12, pp. 5283-5298
Open Access | Times Cited: 6
Showing 6 citing articles:
Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis
Francisco Cézar Aquino de Moraes, Caroline R. M. Pereira, Vitor Kendi Tsuchiya Sano, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Francisco Cézar Aquino de Moraes, Caroline R. M. Pereira, Vitor Kendi Tsuchiya Sano, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Understanding of chemotherapeutic resistance: With special reference to breast cancer
Harmanjit Singh, Dwividendra Kumar Nim, Pankaj Kumar, et al.
Elsevier eBooks (2025), pp. 173-206
Closed Access
Harmanjit Singh, Dwividendra Kumar Nim, Pankaj Kumar, et al.
Elsevier eBooks (2025), pp. 173-206
Closed Access
Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes
Chun‐Ming Chang, Ho Yin Pekkle Lam
Anticancer Research (2024) Vol. 44, Iss. 6, pp. 2271-2285
Open Access | Times Cited: 3
Chun‐Ming Chang, Ho Yin Pekkle Lam
Anticancer Research (2024) Vol. 44, Iss. 6, pp. 2271-2285
Open Access | Times Cited: 3
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
Marianna Talia, Francesca Cirillo, Domenica Scordamaglia, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Marianna Talia, Francesca Cirillo, Domenica Scordamaglia, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Breaking through therapeutic barriers: Insights into CDK4/6 inhibition resistance in hormone receptor-positive metastatic breast Cancer
Yang Zheng, Zeyuan Zhang, Dan Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189174-189174
Closed Access | Times Cited: 2
Yang Zheng, Zeyuan Zhang, Dan Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189174-189174
Closed Access | Times Cited: 2
Generative Modelling of Oncogene-carrying Extrachromosomal Circular DNA Biogenesis and Dynamics in Cells
János Haskó, Weijia Feng, Aram Arshadi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
János Haskó, Weijia Feng, Aram Arshadi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
